These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. Nobels FR; Kwekkeboom DJ; Coopmans W; Hoekstra R; De Herder WW; Bouillon R; Lamberts SW J Clin Endocrinol Metab; 1993 Sep; 77(3):784-9. PubMed ID: 7690365 [TBL] [Abstract][Full Text] [Related]
5. Gonadotroph cell adenomas of the pituitary. Snyder PJ Endocr Rev; 1985; 6(4):552-63. PubMed ID: 2416559 [TBL] [Abstract][Full Text] [Related]
6. Gonadotroph adenoma with secondary hypersecretion of testosterone. Chamoun R; Layfield L; Couldwell WT World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183 [TBL] [Abstract][Full Text] [Related]
7. Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. Daneshdoost L; Gennarelli TA; Bashey HM; Savino PJ; Sergott RC; Bosley TM; Snyder PJ J Clin Endocrinol Metab; 1993 Nov; 77(5):1352-5. PubMed ID: 8077332 [TBL] [Abstract][Full Text] [Related]
8. Abnormal response of luteinizing hormone beta subunit to thyrotrophin-releasing hormone in patients with non-functioning pituitary adenoma. Gil-del-Alamo P; Pettersson KS; Saccomanno K; Spada A; Faglia G; Beck-Peccoz P Clin Endocrinol (Oxf); 1994 Nov; 41(5):661-6. PubMed ID: 7828356 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. Daneshdoost L; Pavlou SN; Molitch ME; Gennarelli TA; Savino PJ; Sergott RC; Bosley TM; River JE; Vale WW; Snyder PJ J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048 [TBL] [Abstract][Full Text] [Related]
10. Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine. Kwekkeboom DJ; de Jong FH; Lamberts SW J Clin Endocrinol Metab; 1989 Jun; 68(6):1128-35. PubMed ID: 2542356 [TBL] [Abstract][Full Text] [Related]
11. Serum bioactive and immunoreactive follicle-stimulating hormone in prostatic cancer patients during gonadotropin-releasing hormone agonist treatment and after orchidectomy. Huhtaniemi IT; Dahl KD; Rannikko S; Hsueh AJ J Clin Endocrinol Metab; 1988 Feb; 66(2):308-13. PubMed ID: 3123510 [TBL] [Abstract][Full Text] [Related]
12. Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. Snyder PJ; Bashey HM; Kim SU; Chappel SC J Clin Endocrinol Metab; 1984 Dec; 59(6):1169-75. PubMed ID: 6436288 [TBL] [Abstract][Full Text] [Related]
13. In vitro secretion of FSH by cultured clinically nonfunctioning and gonadotroph pituitary adenomas is directly correlated with locally produced levels of activin A. Wessels HT; Hofland LJ; van der Wal R; van Gastel L; van Koetsveld PM; de Herder WW; de Jong FH Clin Endocrinol (Oxf); 2001 Apr; 54(4):485-92. PubMed ID: 11318784 [TBL] [Abstract][Full Text] [Related]
14. Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture. Snyder PJ; Bashey HM; Phillips JL; Gennarelli TA J Clin Endocrinol Metab; 1985 Dec; 61(6):1061-5. PubMed ID: 2414310 [TBL] [Abstract][Full Text] [Related]
15. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas. Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538 [TBL] [Abstract][Full Text] [Related]
16. Inhibin and follicle-stimulating hormone levels in gonadotroph adenomas: evidence of a positive correlation with tumour volume in men. Lahlou N; Le Nestour E; Chanson P; Seret-Bégué D; Bouchard P; Roger M; Warnet A Clin Endocrinol (Oxf); 1993 Mar; 38(3):301-9. PubMed ID: 8458102 [TBL] [Abstract][Full Text] [Related]
17. New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist. McGrath GA; Goncalves RJ; Udupa JK; Grossman RI; Pavlou SN; Molitch ME; Rivier J; Vale WW; Snyder PJ J Clin Endocrinol Metab; 1993 May; 76(5):1363-8. PubMed ID: 8496331 [TBL] [Abstract][Full Text] [Related]